Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...

Shares of Eli Lilly are up more than 130% in the past year, but this company's moves are far from finished.

Eli Lilly shares tumbled Tuesday after the drugmaker lowered its revenue forecast for the 2024 fiscal year.

On June 23, Eli Lilly and Company (NYSE:LLY) declared a quarterly dividend of $1.50 per share, which was in line with its ...

Eli Lilly (LLY) stock is trading near its all-time highs, with the shares only about 5% away from the record levels set in August. With the shares up nearly 68% in the past 52 weeks and 58.5% year ...

Eli Lilly's stock isn't cheap The company's stock trades at a hefty 39 times forward earnings. That's very high for a pharma company and more than twice its main GLP-1 competitor, Novo Nordisk.

Eli Lilly’s expectations for sales in the fourth quarter of last year missed forecasts, driven by lower-than-expected sales of its diabetes and obesity drugs.

In total, Lilly recorded 36% quarterly sales growth, and profits grew 68%. Is Eli Lilly stock a buy? Expect more of the same as this year progresses. Management raised its full-year sales forecast ...

Shares of Eli Lilly are up more than 130% in the past year, but this company's moves are far from finished.

Let's dig into what is fueling Lilly's business right now and why a stock split could make sense. Moreover, let's see if investing in Eli Lilly stock now is a good idea.